| Future Health Pharma GmbH - Ovaleap 300 IU/0.5 ml, Injektionslösung |
| 66255 | | 01 | | Ovaleap 300 IU/0.5 ml | | Injektionslösung | | G03GA05 | | Follitropin alfa | | 28.08.2018 | | |
|
| Composition |
| follitropinum alfa 300 U.I., natrii dihydrogenophosphas dihydricus, mannitolum, polysorbatum 20, antiox.: methioninum 250 µg, conserv.: alcohol benzylicus 5 mg, benzalkonii chloridum 10 µg, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Follitropine Alfa | 300U.I. / 0.5ml |
| | BAG: Principe actif | Concentr. |
|---|
| Follitropine Alfa | 300 UI |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Alcohol Benzylicus | 5mg / 0.5ml | conserv. | | Benzalkonium Chlorure | 10µg / 0.5ml | | | Mannitol | | | | Methionine | 250µg / 0.5ml | antiox. | | Sodium Dihydrogenophosphate Dihydrate | | | | Polysorbatum 20 | | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | | 92.05 | 122.20 | A | LS | Oui |
|
